Sculptor Capital’s Celgene Corp CELG Stock Holding History

Sculptor Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,315,508	Closed	-$329M	–	362
2019 Q3	$329M	Buy	3,315,508 +921,198	+38%	+$87.5M	3.55%	3
2019 Q2	$221M	Buy	2,394,310 +719,546	+43%	+$68.3M	1.17%	17
2019 Q1	$158M	Buy	+1,674,764	New	+$146M	0.94%	23

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Sculptor Capital's CELG Position: Q4 2019 in Review

Sculptor Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,315,508 shares — an estimated $329M sold.

Sculptor Capital first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $329M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Sculptor Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Sculptor Capital sold 3,315,508 Celgene Corp shares in Q4 2019, an estimated $329M.
Sculptor Capital first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Sculptor Capital's Celgene Corp position peaked at $329M in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sculptor Capital's 13F filing for Q4 2019, filed 14 Feb 2020.